Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia-Reference-Cited by-同舟云学术

Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia

Published:2019-05-30 Issue:4 Volume:186 Page:625-636
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Aydinok Yesim¹,Piga Antonio²,Origa Raffaella³,Mufti Nina⁴,Erickson Anna⁴,North Anne⁴,Waldhaus Katie⁴,Ernst Christine⁴,Lin Jin‐Sying⁴,Huang Norman⁴,Benjamin Richard J.⁴,Corash Laurence⁴^ORCID

Affiliation:

1. Department of Paediatric Haematology and Oncology Ege University Hospital Izmir Turkey

2. Department of Clinical and Biological Sciences University of Turin Turin Italy

3. Ospedale Pediatrico Microcitemico Universita di Cagliari Cagliari Italy

4. Cerus Corporation Concord CA USA

Funder

Ege University Hospital Blood Centre, Izmir, Turkey

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.15963

Reference21 articles.

1. Risks of red blood cell alloimmunization in transfusion-dependent β-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review

2. Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients

3. Red blood cells treated with the amustaline (S-303) pathogen reduction system: a transfusion study in cardiac surgery

4. Red blood cell concentrates treated with the amustaline (S-303) pathogen reduction system and stored for 35 days retain post-transfusion viability: results of a two-centre study

5. Multiple HBV transfusion transmissions from undetected occult infections: revising the minimal infectious dose

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo genotoxicity assessment of N‐(‐9 acridinyl)‐b‐alanine hydrochloride (S‐300) using a validated Pig‐a mutagenesis assay;Transfusion;2024-05-08

2. Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study—protocol for a phase 3, randomized, controlled trial;Trials;2023-12-11

3. Optimizing RBC Transfusion Outcomes in Patients with Acute Illness and in the Chronic Transfusion Setting;Transfusion Medicine Reviews;2023-10

4. Transfusion management in thalassemia;Annals of the New York Academy of Sciences;2023-08-02

5. Proceedings of the 2022 NHLBI and OASH state of the science in transfusion medicine symposium;Transfusion;2023-04-02